Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jacep.2015.05.008 http://scihub22266oqcxt.onion/10.1016/j.jacep.2015.05.008 29759319!ä!29759319 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JACC+Clin+Electrophysiol 2015 ; 1 (4): 315-322 Nephropedia Template TP {{tp|p=29759319|t=2015. Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures |pdf=|usr=}}{{29759319}} gab.com Text Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures JO: JACC Clin Electrophysiol http://www.kidney.de/pget.php?&tw=1&pmid=29759319 #FOAvip OBJECTIVES: The purpose of this study was to examine the role of mexiletine, a late sodium current (I(Na-L)) blocker, in acute termination of torsades de pointes (TdP) refractory to conventional therapy in acquired long QT syndromes (LQTS). BACKGROUND: Long QT interval can predispose to TdP and is therefore associated with significant mortality. Currently, there is no available pharmacotherapy to target directly the ionic basis of most LQTS for the acute termination of TdP. Earlier evidence highlighted the role of I(Na-L) in the pathophysiology of long QT and TdP, particularly in patients with congenital LQTS. METHODS: Twelve patients with TdP caused by acquired LQTS were treated with mexiletine after failure of conventional treatment including discontinuation of QT-prolonging drugs, intravenous administration of magnesium, and correction of serum electrolyte abnormalities. RESULTS: No recurrence of TdP occurred within 2 h after initiation of treatment with mexiletine in all 12 patients. Macro T-wave alternans accompanied by QT prolongation, an electrocardiographic precursor of TdP that was seen in 3 patients, was also abolished by mexiletine. Treatment with mexiletine shortened the QTc interval from 599 +/- 27 ms to 514 +/- 16 ms (p = 0.001). The interval from the peak to the end of the T-wave (T(p-e) interval) decreased from 145 +/- 18 ms to 106 +/- 9 ms (p = 0.005). The T(p-e)/QT ratio decreased from 0.27 +/- 0.02 to 0.23 +/- 0.018 (p = 0.01). Mexiletine had no significant effect on QRS complex duration. CONCLUSIONS: I(Na-L) blockade with mexiletine may be an effective treatment approach to terminate refractory TdP from several acquired causes of LQTS. Twit Text FOAVip Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures ????JACC Clin Electrophysiol http://www.kidney.de/pget.php?&tw=1&pmid=29759319 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29759319 #FOAvip English Wikipedia <ref>{{Cite pmid|29759319}}</ref> Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures #MMPMID29759319 Badri M; Patel A; Patel C; Liu G; Goldstein M; Robinson VM; Xue X; Yang L; Kowey PR; Yan GX JACC Clin Electrophysiol 2015[Aug]; 1 (4): 315-322 PMID29759319show ga OBJECTIVES: The purpose of this study was to examine the role of mexiletine, a late sodium current (I(Na-L)) blocker, in acute termination of torsades de pointes (TdP) refractory to conventional therapy in acquired long QT syndromes (LQTS). BACKGROUND: Long QT interval can predispose to TdP and is therefore associated with significant mortality. Currently, there is no available pharmacotherapy to target directly the ionic basis of most LQTS for the acute termination of TdP. Earlier evidence highlighted the role of I(Na-L) in the pathophysiology of long QT and TdP, particularly in patients with congenital LQTS. METHODS: Twelve patients with TdP caused by acquired LQTS were treated with mexiletine after failure of conventional treatment including discontinuation of QT-prolonging drugs, intravenous administration of magnesium, and correction of serum electrolyte abnormalities. RESULTS: No recurrence of TdP occurred within 2 h after initiation of treatment with mexiletine in all 12 patients. Macro T-wave alternans accompanied by QT prolongation, an electrocardiographic precursor of TdP that was seen in 3 patients, was also abolished by mexiletine. Treatment with mexiletine shortened the QTc interval from 599 +/- 27 ms to 514 +/- 16 ms (p = 0.001). The interval from the peak to the end of the T-wave (T(p-e) interval) decreased from 145 +/- 18 ms to 106 +/- 9 ms (p = 0.005). The T(p-e)/QT ratio decreased from 0.27 +/- 0.02 to 0.23 +/- 0.018 (p = 0.01). Mexiletine had no significant effect on QRS complex duration. CONCLUSIONS: I(Na-L) blockade with mexiletine may be an effective treatment approach to terminate refractory TdP from several acquired causes of LQTS. äMexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT (epmc).pdf DeepDyve Pubget Overpricing